MedPath

Long-term Outcomes in Terms of Disability and Quality of Life for Patients Undergoing Posterior Cranial Fossa Craniectomy in the Context of Compressive Cerebellar Hematoma

Completed
Conditions
Craniectomy
Quality of Life
Cerebellar Haematoma
Handicaps Physical
Handicap Mental
Interventions
Behavioral: SF36 questionary
Registration Number
NCT04672785
Lead Sponsor
University Hospital, Grenoble
Brief Summary

Posterior cranial fossa craniectomy has been shown to improve patient survival. The level of autonomy, disability and quality of life of survivors has been little studied and still underresearched,.

In this context, an assessment of the level of disability and of the quality of life after performing a posterior craniectomy seems relevant.

Detailed Description

Investigators are carrying out a retrospective observational, single-center study, in three intensive care units in the Grenoble Hospital Center. Every patients who underwent a posterior fossa craniectomy for a cerebellar hematoma at Grenoble University Hospital between 01/01/2010 and 01/01/2020 were enrolled in this study. The main objective is to assess the level of disability and the quality of life of patients who have had a posterior cranial fossa craniectomy. The primary outcome is the mRS(Modified Rankin score) measured at least one year following the ICU discharge. Secondary outcomes are the mRS(Modified Rankin Score) measured at discharge from the rehabilitation department, the GOS (Glasgow Outcome score) measured at least one year following the discharge from intensive care, and the SF36 (The Short Form 36)from the medical outcome study, score assessing the quality of life, collected via phone call.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • Patient who underwent a posterior cranial fossa craniectomy in the context of an acute cerebellar hematoma between January 01, 2012 to January 01, 2020.
  • Adult man or woman
  • Hospitalized in intensive care
  • No opposition from the patient or a loved one to a telephone contact to determine the SF36 (The Short Form) quality of life scale, from the medical outcome study.
Exclusion Criteria
  • Subject under guardianship or subject deprived of liberty
  • Early limitation of active therapy before 48 hours.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients who underwent a posterior fossa craniectomy for a cerebellar hematomaSF36 questionary-
Primary Outcome Measures
NameTimeMethod
Evaluate the level of handicapthrough study completion, an average of 1 years post admission

The mRS (Modified Ranking score) measured at least one year following the ICU discharge during the consultation after hospitalization in the medical file

Secondary Outcome Measures
NameTimeMethod
Global quality of life scorefrom january 2020, during 6 months

the SF36 score assessing the quality of life, collected via phone call.

Neurological recoveryfrom january 2020, during 6 months

the GOS (Glasgow Outcome Scale) score measured at least one year following the discharge from intensive care. It goes from 1 to 5.

1 corresponds to death 5.Good Recovery

Trial Locations

Locations (1)

CHUGA

🇫🇷

Grenoble, France

© Copyright 2025. All Rights Reserved by MedPath